Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Ophthalmol ; 31(2): NP119-NP122, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31390886

RESUMO

PURPOSE: To report three cases of juvenile myasthenia gravis aged between 18 and 24 months with ocular symptoms as their first presentation. METHOD: A case series. RESULTS: We present a case series of juvenile myasthenia gravis in a tertiary centre in Malaysia. Two of the three cases consist of a pair of twins who presented with ptosis of bilateral eyes; the first twin presented 4 months later than the second twin. These two cases were positive for anti-acetylcholine receptor antibodies and had generalized myasthenia gravis, whereas the other case was negative for receptor antibodies and was purely ocular myasthenia gravis. CONCLUSION: Juvenile myasthenia gravis is relatively rare in toddlers. Early diagnosis and commencement of treatment is important to slow the progression of the disease and avoiding life-threatening events.


Assuntos
Blefaroptose/diagnóstico , Doenças em Gêmeos/diagnóstico , Miastenia Gravis/diagnóstico , Gêmeos Monozigóticos , Autoanticorpos/sangue , Blefaroptose/tratamento farmacológico , Blefaroptose/genética , Pré-Escolar , Inibidores da Colinesterase/uso terapêutico , Doenças em Gêmeos/tratamento farmacológico , Doenças em Gêmeos/genética , Quimioterapia Combinada , Feminino , Glucocorticoides/uso terapêutico , Humanos , Lactente , Miastenia Gravis/tratamento farmacológico , Miastenia Gravis/genética , Prednisolona/uso terapêutico , Brometo de Piridostigmina/uso terapêutico , Receptores Colinérgicos/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA